Strategic Analysis of Indian Biosimilar Market

Strategic Analysis of Indian Biosimilar Market

 

RELEASE DATE
10-May-2011
REGION
Asia Pacific
Research Code: P43E-01-00-00-00
SKU: HC02321-AP-MR_08313
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC02321-AP-MR_08313
$4,950.00
DownloadLink
ENQUIRE NOW

Description

This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.

Table of Contents

Brief Summary of Indian Biosimilar Market

  • Executive Summary of the Biosimilar market
  • Future Impact

Overview of Global Biosimilar Market

  • Introduction to Biosimilars
  • Global Population Demographics
  • Key Biodrugs
  • Types of Products Manufactured by Major Participants
  • Market Size of Biosimilars: Global
  • Market Size: Biologic Patents Expiring in 2011-2016
  • Market Size: Biologics Patents Expiring 2016-2019
  • Market Size : Worldwide Sales of Key Biodrugs
  • Market Opportunities
  • Market Size of Biosimilars: Revenue Forecasts
  • Major Participants - Global
  • Major Participants - Trends

Overview if Indian Biosimilar Market

  • Overview of Indian Biosimilar Market
  • Timeline of Indian Market
  • Indian Market Portfolio
  • Domestic Market Potential
  • Market Drivers Ranked in Order of Impact
  • General Factors favoring the market
  • Market Restraints Ranked in Order of Impact
  • Hurdles faced by Indian Participants
  • Domestic Market Potential - Observed Trends in Market
  • Export Potential - Overview
  • Export Potential - Expansion Strategy of Indian Participants
  • Overview of Highly Regulated Markets: Europe
  • Overview of Highly Regulated Markets: The United States
  • Overview of Semi-regulated Markets: China
  • Cost Advantage of India
  • Biosimilar Market in India: Revenue Forecasts

Overview of Regulatory Scenario

  • Indian Regulations for Biosimilars
  • International Regulatory Authorities European Medicines Agency (EMA)
  • International Regulatory Authorities US-FDA

Overview of Major Participants in the Indian Market

  • Biocon
  • Dr. Reddy’s
  • Ranbaxy
  • Wockhardt
  • Intas Biopharmaceuticals
  • Shantha Biotech

Overview of Historical trends and Future Impact

  • 2001-2010: A Historical View of the Biosimilar Market
  • 2010-2015: Frost & Sullivan View on the Biosimilars Market

Overview of Chinese Biosimilar Market

  • Overview of Biosimilar Market in China
  • China – Major Participants

Frost and Sullivan: Overview

  • Who is Frost and Sullivan
  • What makes us unique
  • T.E.A.M. Methodology
  • Global Perspective
Related Research
This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number P43E-01-00-00-00
Is Prebook No